NASDAQ:COYA - Nasdaq - US22407B1089 - Common Stock - Currency: USD
Here is how Auna S.A. (AUNA) and Coya Therapeutics, Inc. (COYA) have performed compared to their sector so far this year.
Mentions: AUNA
Here is how Coya Therapeutics, Inc. (COYA) and Doximity (DOCS) have performed compared to their sector so far this year.
Mentions: DOCS
The consensus price target hints at a 144.7% upside potential for Coya Therapeutics, Inc. (COYA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Enters into Agreement with Bradley L. Radoff and Michael Torok
Mentions: AVIR
We recently published a list of Gold, Biopharma Firms Dominate Friday’s 10 Top Performing Stocks. In this article, we are going to take a look at where Kingsoft Cloud Holdings Limited (NASDAQ:KC) stands against other Friday’s top performing stocks. The stock market finished the trading week on a positive note, wiping out earlier losses on Friday, […]
We recently published a list of Top 9 Healthcare Stocks to Buy According to Billionaire David Einhorn. In this article, we are going to take a look at where Galapagos NV (NASDAQ:GLPG) stands against other top healthcare stocks to buy according to Billionaire David Einhorn. Wall Street has come down crashing on President Donald Trump’s […]
We recently published a list of Top 9 Healthcare Stocks to Buy According to Billionaire David Einhorn. In this article, we are going to take a look at where Coya Therapeutics, Inc. (NASDAQ:COYA) stands against other top healthcare stocks to buy according to Billionaire David Einhorn. Wall Street has come down crashing on President Donald […]
We recently published a list of Top 9 Healthcare Stocks to Buy According to Billionaire David Einhorn. In this article, we are going to take a look at where Gain Therapeutics, Inc. (NASDAQ:GANX) stands against other top healthcare stocks to buy according to Billionaire David Einhorn. Wall Street has come down crashing on President Donald […]
We recently published a list of the 13 High-Dividend Stocks to Invest In Under $10. In this article, we are going to take a look at where Nordic American Tankers Limited (NYSE:NAT) stands against other high-dividend stocks under $10. Investors often favor dividend stocks for their long-term potential, with their appeal stemming from the consistent […]
Coya Therapeutics, Inc. (COYA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
The consensus price target hints at a 149.6% upside potential for Coya Therapeutics, Inc. (COYA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.